Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept effects on endothelial function and carotid intima-media thickness in active ankylosing spondylitis
2007-003096-39Phase 4Terminated
- Sponsor
- Wyeth
- Start
- Mar 2009
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ankylosing spondylitis (AS) comparing Etanercept with Placebo (2 arms). Primary endpoint: Mean change in flow-mediated dilatation. Started Mar 2009; status: terminated.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on 2007-003096-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003096-39.